| Biochemistry & Pharmacology Portfolio - FY 2007 Awards | ||||
| Grant | PI Name | Institution | Project Title | PO Name |
| 5R01 CA112519-02 | ALI-OSMAN, FRANCIS | DUKE UNIVERSITY | Novel Targeted Therapeutics for CNS Malignancies | LEES, ROBERT |
| 5R01 CA080195-09 | ARTEAGA, CARLOS L | VANDERBILT UNIVERSITY | Erbb2 targeted antitumor strategies in breast cancer | FORRY-SCHAUDIES, SUZANNE |
| 2R01 CA077091-04A2 | AU, JESSIE L-S | OHIO STATE UNIVERSITY | Telomeres, telomerase and chemotherapy: Bench to bedside | ARYA, SURESH |
| 5R01 CA104661-04 | AWASTHI, SANJAY | UNIVERSITY OF TEXAS ARLINGTON | Role of RALBP1 in Xenobiotic and Radiation Resistance | FORRY-SCHAUDIES, SUZANNE |
| 2R01 CA077495-09A1 | AWASTHI, SANJAY | UNIVERSITY OF TEXAS ARLINGTON | Mechanism of Drug Transport in Lung Cancer Cells | FORRY-SCHAUDIES, SUZANNE |
| 2R44 CA106137-02A1 | AYEHUNIE, SEYOUM | MATTEK CORPORATION | In Vitro Assay for Chemical Allergens | SONG, MIN-KYUNG |
| 5R01 CA122356-02 | BAE, YOU HAN | UNIVERSITY OF UTAH | Micelle surface engineering for active targeting by acidic tumor extracellular pH | FU, YALI |
| 5R01 CA101850-04 | BAE, YOU HAN | UNIVERSITY OF UTAH | Engineered intelligent micelle for tumor pH targeting | FU, YALI |
| 5R01 CA108975-02 | BAEK, SEUNG JOON | UNIVERSITY OF TENNESSEE KNOXVILLE | PPAR-gamma ligands in colorectal cancer | ARYA, SURESH |
| 5R01 CA075080-10 | BALDWIN JR, ALBERT S | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | NF-kappaB as a Therapeutic Target for Prostate Cancer | ARYA, SURESH |
| 1R01 CA111803-01A2 | BALK, STEVEN P | BETH ISRAEL DEACONESS MEDICAL CENTER | Targeting AR-NCoR Interaction in Prostate Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA118213-02 | BALTHASAR, JOSEPH P | STATE UNIVERSITY OF NEW YORK AT BUFFALO | Pharmacokinetic strategies to optimize IP chemotherapy | FU, YALI |
| 5R01 CA102688-04 | BARON, VERONIQUE T | SIDNEY KIMMEL CANCER CENTER | Validation of a New Target for Prostate Cancer Therapy | ARYA, SURESH |
| 1R21 CA121782-01A1 | BARTON, BEVERLY E | UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL | Cell-targeting peptide nucleic acids for hormone-refractory prostate cancer | FU, YALI |
| 1R01 CA124763-01A1 | BASU, SUJIT | MAYO CLINIC COLL OF MEDICINE, ROCHESTER | The Role of Dopamine in Colon Cancer Neovascularization | FORRY-SCHAUDIES, SUZANNE |
| 5R21 CA118265-02 | BASU, SUJIT | MAYO CLINIC COLL OF MEDICINE, ROCHESTER | The Neurotransmitter Dopamine and Gastric Cancer | SONG, MIN-KYUNG |
| 5R01 CA122383-02 | BATES, PAULA J | UNIVERSITY OF LOUISVILLE | Tumor-Targeting Oligonucleotides | LEES, ROBERT |
| 5R01 CA040570-20 | BECK, WILLIAM T | UNIVERSITY OF ILLINOIS AT CHICAGO | Characteristics of Multidrug Resistance in Human Tumors | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA114116-03 | BEDFORD, MARK T | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Small Molecule Regulators of Arginine Methyltransferases | SONG, MIN-KYUNG |
| 5R01 CA106312-03 | BEERMAN, TERRY A | ROSWELL PARK CANCER INSTITUTE CORP | Cellular Responses to Cancer Drug-Induced Genomic Breaks | ARYA, SURESH |
| 5R01 CA106713-03 | BENBROOK, DORIS M. | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR | Mechanism of SHeA2 Action in Ovarian Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA097127-05 | BENEDICT, WILLIAM F | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | RB4 Intravesical Gene Therapy: Mechanisms of Cell Death | ARYA, SURESH |
| 5R01 CA036773-25 | BENZ, CHRISTOPHER | BUCK INSTITUTE FOR AGE RESEARCH | Therapeutic Modulation of Breast Cancer Oncogenes | ARYA, SURESH |
| 5R01 CA118408-03 | BERDIS, ANTHONY J | CASE WESTERN RESERVE UNIVERSITY | Non-natural Nucleoside Inhibitors of DNA Polymerases | LEES, ROBERT |
| 5R01 CA008010-44 | BERTINO, JOSEPH R | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH | Mechanism of Action of Folate Antagonist | WOLPERT, MARY K. |
| 1R01 CA123207-01A1 | BHALLA, KAPIL N | MEDICAL COLLEGE OF GEORGIA (MCG) | Histone Deacetylase Inhibitor Based Therapy of AML | ARYA, SURESH |
| 5R44 CA108392-03 | BISGROVE, DWAYNE ALLAN | SYSTEM BIOSCIENCES, LLC (SBI) | Functional Dissection of Signaling Pathways | SONG, MIN-KYUNG |
| 5R01 CA111542-03 | BJORNSTI, MARY-ANN | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | SUMOylation and Cell Sensitivity to Top1 Poisons | ARYA, SURESH |
| 2R01 CA058755-13A1 | BJORNSTI, MARY-ANN | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | DNA Topoisomerase-Camptothecin Interactions | ARYA, SURESH |
| 5R01 CA085939-08 | BLACK, MARGARET E | WASHINGTON STATE UNIVERSITY | Improving Suicide Genes for Cancer Gene Therapy | ARYA, SURESH |
| 5U01 CA120458-02 | BLAGG, BRIAN S J | UNIVERSITY OF KANSAS LAWRENCE | Development and Evaluation of Purine and Coumarin Based Hsp90 Inhibitors` | LEES, ROBERT |
| 5R01 CA114393-03 | BLAGG, BRIAN S J | UNIVERSITY OF KANSAS LAWRENCE | HTS Assays for Hsp90 Inhibitors | SONG, MIN-KYUNG |
| 5U01 CA109265-02 | BLAGG, BRIAN S J | UNIVERSITY OF KANSAS LAWRENCE | Hsp90 Inhibitors | LEES, ROBERT |
| 5R01 CA115526-02 | BOGER, DALE L | SCRIPPS RESEARCH INSTITUTE | Vindoline and Vinblastine | LEES, ROBERT |
| 5R01 CA042056-24 | BOGER, DALE L | SCRIPPS RESEARCH INSTITUTE | Antitumor Antibiotics | LEES, ROBERT |
| 2R01 CA041986-20A1 | BOGER, DALE L | SCRIPPS RESEARCH INSTITUTE | The Antitumor Antibiotics CC-1065 and the Duocarmycins | LEES, ROBERT |
| 5R01 CA041101-23 | BOGER, DALE L | SCRIPPS RESEARCH INSTITUTE | Biologically Active Cyclic Peptides | LEES, ROBERT |
| 5R01 CA108558-04 | BOGLER, OLIVER | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Treatment of Malignant Gliomas with 2-5A-anti-hTR | ARYA, SURESH |
| 5R03 CA123004-02 | BOLD, RICHARD J | UNIVERSITY OF CALIFORNIA DAVIS | Targeting AKT as a novel therapy in pancreatic cancer | FORRY-SCHAUDIES, SUZANNE |
| 2R01 CA088986-05 | BOONS, GEERT-JAN | UNIVERSITY OF GEORGIA (UGA) | A fully synthetic carbohydrate-based cancer vaccine | LEES, ROBERT |
| 5R01 CA102792-05 | BOOTHMAN, DAVID A | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | Use of Beta-Lapachone for Lung Cancer Chemotherapy | FU, YALI |
| 5P01 CA097323-05 | BRODEUR, GARRETT M | CHILDREN'S HOSPITAL OF PHILADELPHIA | Neuroblastoma Biology and Therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA027440-28 | BRODIE, ANGELA M. | UNIVERSITY OF MARYLAND BALTIMORE | ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER | LEES, ROBERT |
| 5R01 CA116590-02 | BRONICH, TATIANA K | UNIVERSITY OF NEBRASKA MEDICAL CENTER | Cross-linked Polymer Micelles in Cancer Therapy | FU, YALI |
| 5R01 CA106646-03 | BROWN, KATHLYNN C | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | Diagnostic & targeting reagents for lung cancer | SONG, MIN-KYUNG |
| 5R01 CA105435-05 | BROWN, MILTON L. | GEORGETOWN UNIVERSITY | Sodium Channel Blockers as Inhibitors of Prostate Cancer | LEES, ROBERT |
| 1R43 CA130272-01 | BUDDE, RAYMOND J | HOUSTON PHARMACEUTICALS, INC. | Development of the first topo II inhibitor for brain tumors | LEES, ROBERT |
| 1R43 CA126318-01A1 | BUDDE, RAYMOND J | HOUSTON PHARMACEUTICALS, INC. | Thermally Targeted Delivery of DOX | SONG, MIN-KYUNG |
| 1R01 CA127258-01 | BURGER, ANGELIKA M | UNIVERSITY OF MARYLAND BALTIMORE | The BCA2 Ubiquitin E3 Ligase as a Target in Breast Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA099036-05 | BURKE, DANIEL J | UNIVERSITY OF VIRGINIA CHARLOTTESVILLE | Identifying Inhibitors of the APC/C Using Yeast Mutants | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA108488-04 | BURKE, STEVEN D. | UNIVERSITY OF WISCONSIN MADISON | Expeditious Synthesis of Complexity and Diversity | LEES, ROBERT |
| 5R01 CA106673-03 | BURKE, STEVEN D. | UNIVERSITY OF WISCONSIN MADISON | Macrocyclic Enyne Methathesis and Its Applications | LEES, ROBERT |
| 5R44 CA110885-03 | BURKHART, CATHERINE A | CLEVELAND BIOLABS, INC. | N-myc Targeted Therapeutics for Childhood Neuroblastoma | SONG, MIN-KYUNG |
| 5R01 CA085935-07 | CABRAL, FERNANDO R | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON | Tubulin Mutations and Paclitaxel Resistance | FU, YALI |
| 1R21 CA122327-01A1 | CAO, DELIANG | SOUTHERN ILLINOIS UNIVERSITY SCH OF MED | Aldose Reductase-Like-1, a Novel Hepatocellular Carcinoma Drug Resistant Protein | SONG, MIN-KYUNG |
| 5R01 CA114107-03 | CARDENAS-CORONA, MARIA E | DUKE UNIVERSITY | Signaling mechanisms by the rapamycin target: Tor kinase | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA116491-01A2 | CARRIER, FRANCE | UNIVERSITY OF MARYLAND BALTIMORE | Biomodulation of anticancer drugs targeting DNA | ARYA, SURESH |
| 5R01 CA051085-18 | CASERO, ROBERT A | JOHNS HOPKINS UNIVERSITY | Spermine N1-Acetylase Induction in Lung Cancers | WOLPERT, MARY K. |
| 1R41 CA126317-01A1 | CASTOR, TREVOR PERCIVAL | APHIOS CORPORATION | Alkylating Vitamin D Derivative | FU, YALI |
| 5R01 CA035635-22 | CHAIRES, JONATHAN B. | UNIVERSITY OF LOUISVILLE | Specificity of Intercalation Reactions | FU, YALI |
| 5R01 CA109821-04 | CHAMBERS, TIMOTHY C | UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK | BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action | ARYA, SURESH |
| 5R01 CA084480-07 | CHANEY, STEPHEN G | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | Error-Prone Replicative Bypass of Platinum Adducts | WOLPERT, MARY K. |
| 5R01 CA089078-07 | CHANG, XIU-BAO | MAYO CLINIC COLL OF MED, MAYO CLINIC AZ | Mechanism of ATP-dependent transport by MRP1 protein | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA094851-05 | CHEN, JIANDONG | H. LEE MOFFITT CANCER CTR & RES INST | Pharmacological rescue of mutant p53 function | WOLPERT, MARY K. |
| 5R01 CA120272-02 | CHEN, JING | EMORY UNIVERSITY | Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA113656-02 | CHEN, WEI | DUKE UNIVERSITY | Innovative Assays for Oncogenic Hedgehog Signaling | SONG, MIN-KYUNG |
| 5R01 CA100241-05 | CHENG, GENHONG | UNIVERSITY OF CALIFORNIA LOS ANGELES | The Apoptotic Role of MEKK1 in Cancer Chemotherapy | FORRY-SCHAUDIES, SUZANNE |
| 7R01 CA107078-05 | CHENG, JIN Q | H. LEE MOFFITT CANCER CTR & RES INST | Disruption of AKT Pathway for Cancer Intervention | LEES, ROBERT |
| 5R01 CA107078-04 | CHENG, JIN Q | UNIVERSITY OF SOUTH FLORIDA | Disruption of AKT Pathway for Cancer Intervention | LEES, ROBERT |
| 5R01 CA063477-12 | CHENG, YUNG-CHI | YALE UNIVERSITY | Nucleoside Analogs as Anticancer Compounds | SONG, MIN-KYUNG |
| 3R01 CA063477-11A1S1 | CHENG, YUNG-CHI | YALE UNIVERSITY | Nucleoside Analogs as Anticancer Compounds | SONG, MIN-KYUNG |
| 5R01 CA116428-03 | CHESNEY, JASON A | UNIVERSITY OF LOUISVILLE | Targeting of 6-Phosphofructo-2 kinase in Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA076193-10 | CHIANG, GARY G | BURNHAM INSTITUTE FOR MEDICAL RESEARCH | Cellular Pharmacology of Rapamycin | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA119001-02 | CHIOSIS, GABRIELA | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Assays for rapid identification of Hsp70 modulators | SONG, MIN-KYUNG |
| 5R01 CA109518-03 | CHITAMBAR, CHRISTOPHER R | MEDICAL COLLEGE OF WISCONSIN | Cellular Targets for Gallium Compounds in Lymphoma | FORRY-SCHAUDIES, SUZANNE |
| 1R43 CA130228-01 | CHOI, ANTHONY H | BEXION PHARMACEUTICALS, INC. | A novel biotherapeutic treatment for prostate cancer | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA112446-01A2 | CHOU, KAI-MING | UNIVERSITY OF SOUTH ALABAMA | DNA Lesion Bypass Polymerases and Therapeutic Compounds | ARYA, SURESH |
| 1R01 CA129814-01 | CICHOWSKI, KAREN | BRIGHAM AND WOMEN'S HOSPITAL | Elucidating the role of the mTOR pathway in NF1-related tumorigenesis | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA024487-29 | CLARDY, JON | HARVARD UNIVERSITY (MEDICAL SCHOOL) | Applications of Natural Products to Chemical Biology | FU, YALI |
| 5R01 CA059021-15 | CLARDY, JON C. | HARVARD UNIVERSITY (MEDICAL SCHOOL) | Structural and Functional Studies on Proteins | LEES, ROBERT |
| 2R01 CA090853-06 | CLARET, FRANCOIS X | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Targeting JAB1 Oncogenic Function in Breast Cancer | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA123159-01A1 | COLE, DAVID J | MEDICAL UNIVERSITY OF SOUTH CAROLINA | TARGETING THE CASM ONCOGENE AS A NOVEL THERAPY FOR PANCREATIC CANCER | ARYA, SURESH |
| 2R01 CA074305-12 | COLE, PHILIP A | JOHNS HOPKINS UNIVERSITY | Chemical Approaches to Protein Phosphorylation | LEES, ROBERT |
| 5R01 CA065875-13 | COLEMAN, ROBERT S | OHIO STATE UNIVERSITY | Azinomycins - Total Synthesis and Mechanism of Action | LEES, ROBERT |
| 5R01 CA066561-11 | COLMAN, ROBERTA F. | UNIVERSITY OF DELAWARE | Glutathione S-Transferases: Novel Regulators of Cellular Stress and Apoptosis | SONG, MIN-KYUNG |
| 5R01 CA016783-32 | COLVIN, OLIVER MICHAEL | DUKE UNIVERSITY | Pharmacology of Cyclophosphamide and Other Alkylators | SONG, MIN-KYUNG |
| 1R21 CA124557-01A1 | CONNELL, PHILIP | UNIVERSITY OF CHICAGO | Inhibition of Recombination DNA Repair in Pancreatic Cancer Cells | SONG, MIN-KYUNG |
| 1R21 CA126903-01 | COUNTER, CHRISTOPHER M | DUKE UNIVERSITY | Developing inhibitors of RalA function for the treatment of pancreatic cancer | SONG, MIN-KYUNG |
| 1R01 CA121680-01A2 | COWAN, NICHOLAS | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | Inhibition of the Tubulin Folding Pathway as a Novel Therapy for Cancer | SONG, MIN-KYUNG |
| 5R01 CA109550-04 | COX, ADRIENNE D | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | Protein prenylation, oncogenesis and novel therapeutics | FORRY-SCHAUDIES, SUZANNE |
| 5R44 CA099217-03 | COX, GEORGE NORBERT | BOLDER BIOTECHNOLOGY, INC. | Long Acting VEGF BInding Proteins for Treating Cancer | LEES, ROBERT |
| 5R01 CA087660-08 | CRAVATT, BENJAMIN F | SCRIPPS RESEARCH INSTITUTE | Chemical Approaches for Activity Based Proteomics | FU, YALI |
| 5U19 CA052955-18 | CREWS, PHILLIP O | UNIVERSITY OF CALIFORNIA SANTA CRUZ | Targeted Discovery of Marine-derived Anticancer Leads | FU, YALI |
| 5R37 CA055254-17 | CROTEAU, RODNEY B | WASHINGTON STATE UNIVERSITY | BIOSYNTHESIS of Taxol | FU, YALI |
| 1R15 CA127888-01 | CRUPPER, SCOTT S | EMPORIA STATE UNIVERSITY | Secondary Metabolite Production in Sorangium cellulosum | FU, YALI |
| 5R01 CA097198-05 | CRYNS, VINCENT L. | NORTHWESTERN UNIVERSITY | Role of alphaB-Crystallin in Cancer Cell Death | FORRY-SCHAUDIES, SUZANNE |
| 5R21 CA115785-02 | CULLEN, JOSEPH J | UNIVERSITY OF IOWA | Mechanisms of Dicumarol-Induced Cytotoxicity | FU, YALI |
| 5R01 CA118562-02 | CUNNINGHAM, BRIAN T | UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN | Label-Free Screening Using Photonic Crystal Sensors for the Apoptotic Pathway | SONG, MIN-KYUNG |
| 5R01 CA098871-03 | CUSACK, JAMES C. | MASSACHUSETTS GENERAL HOSPITAL | The Role of NF-kappaB in Chemotherapy Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5U01 CA089566-07 | CUSHMAN, MARK S | PURDUE UNIVERSITY WEST LAFAYETTE | Novel Indenoisoquinoline Topoisomerase I Inhibitors | FU, YALI |
| 5R01 CA059750-12 | CUTLER, MARY L | HENRY M. JACKSON FDN FOR THE ADV MIL/MED | TOPOISOMERASE I AS AN ANTITUMOR DRUG TARGET | ARYA, SURESH |
| 2R01 CA077859-09 | DALTON, WILLIAM S | H. LEE MOFFITT CANCER CTR & RES INST | Drug Resistance in Multiple Myeloma | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA128002-01 | DAMMAI, VINCENT | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Cellular Factors Promoting Renal Cell Carcinoma | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA103823-29 | DANISHEFSKY, SAMUEL J | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Synthesis of Antiinfective Agents | LEES, ROBERT |
| 4R37 CA028824-29 | DANISHEFSKY, SAMUEL J | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Synthesis of Antitumor Natural Products | LEES, ROBERT |
| 5R01 CA113446-03 | DANKS, MARY K | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | Neural Progenitor Cells as Cancer Therapy Vectors | FU, YALI |
| 5R21 CA122963-02 | DARLING, THOMAS N | HENRY M. JACKSON FDN FOR THE ADV MIL/MED | Novel in vitro and xenograft models to study treatments for tuberous sclerosis | SONG, MIN-KYUNG |
| 5R01 CA115331-08 | DARMANI, NISSAR A | WESTERN UNIVERSITY OF HEALTH SCIENCES | MECHANISMS OF CANNABINOID'S ANTIEMETIC ACTIONS | FU, YALI |
| 5R01 CA107039-03 | DAWSON, MARCIA I | BURNHAM INSTITUTE FOR MEDICAL RESEARCH | Rexinoid Synergy in Prostate Cancer Apoptosis | LEES, ROBERT |
| 5R01 CA090349-07 | DE BRABANDER, JEF KAREL | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | Chemistry and Biology of Antitumor Natural Products | LEES, ROBERT |
| 5R01 CA109174-02 | DEBS, ROBERT J | CALIFORNIA PACIFIC MED CTR RES INSTITUTE | Developing Multi-Genic Anti-Breast Cancer Therapies | ARYA, SURESH |
| 1R01 CA124764-01A1 | DENMEADE, SAMUEL R | JOHNS HOPKINS UNIVERSITY | Fibroblast Activation Protein-alpha Activated Anti-Stromal Prodrug Therpay for Ca | FU, YALI |
| 5R33 CA112144-03 | D'ERRICO, FRANCESCO | YALE UNIVERSITY | Chemotherapy with injectable microdroplets | FU, YALI |
| 5R01 CA111422-03 | DMITROVSKY, ETHAN | DARTMOUTH COLLEGE | Cyclin D as a Retinoid Molecular Target | ARYA, SURESH |
| 5R01 CA081485-08 | DOLAN, M EILEEN | UNIVERSITY OF CHICAGO | Role of DNA In Protecting Against Secondary Leukemias | FORRY-SCHAUDIES, SUZANNE |
| 5R21 CA112436-02 | DORMIDONTOVA, ELENA | CASE WESTERN RESERVE UNIVERSITY | Design of Targeting Enhancement for Drug Delivery | FU, YALI |
| 5R01 CA115626-02 | DORR, ROBERT T | UNIVERSITY OF ARIZONA | Redox-Active Agents for Pancreatic Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5P01 CA094000-05 | EALICK, STEVEN E | CORNELL UNIVERSITY ITHACA | Rational Design of Inhibitors of Polyamine Synthesis | LEES, ROBERT |
| 1R01 CA117874-01A2 | EASTMAN, ALAN | DARTMOUTH COLLEGE | Mechanisms of Resistance to Cell Cycle Checkpoint Kinase Inhibitors | ARYA, SURESH |
| 5R13 CA124132-02 | EASTMAN, ALAN R | GORDON RESEARCH CONFERENCES | 2006 Molecular Therapeutics of Cancer Gordon Research Conference | ARYA, SURESH |
| 5R01 CA050224-14 | EASTMAN, ALAN R | DARTMOUTH COLLEGE | Cell Death Induced by Anticancer Agents | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA098568-04 | ERDREICH-EPSTEIN, ANAT | CHILDREN'S HOSPITAL LOS ANGELES | Brain tumor angiogenesis: Integrin ceramide signaling | ARYA, SURESH |
| 5R01 CA096839-05 | ERICKSON, LEONARD C | INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS | Two Photon Imaging of Drug Uptake Efflux and Modulation | LEES, ROBERT |
| 5R01 CA112278-03 | ESKO, JEFFREY D | UNIVERSITY OF CALIFORNIA SAN DIEGO | Glycoside Inhibitors of Tumor Metastasis | FU, YALI |
| 5R01 CA086061-07 | ESSIGMANN, JOHN M | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Mechanistic Comparison of Cisplatin with Synthetic DNA Repair-Shielding Anticancer | WOLPERT, MARY K. |
| 5R01 CA077743-10 | ESSIGMANN, JOHN M | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Design of Programmable Genotoxins | LEES, ROBERT |
| 5R01 CA110940-06 | ETZKORN, FELICIA A | VIRGINIA POLYTECHNIC INST AND ST UNIV | Designed Inhibitors of Pin1 in Mitosis | LEES, ROBERT |
| 5R01 CA104748-04 | EVERS, BERNARD MARK | UNIVERSITY OF TEXAS MEDICAL BR GALVESTON | Surgical Studies of Signaling Pathways in GI Cancers | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA112102-03 | FALLER, DOUGLAS V | BOSTON UNIVERSITY MEDICAL CAMPUS | Ras Oncoprotein-Targeted Therapy for Cancer | ARYA, SURESH |
| 2R56 CA078754-10 | FARRELL, NICHOLAS P | VIRGINIA COMMONWEALTH UNIVERSITY | Mechanistic Studies on New Platinum Clinical Agents | LEES, ROBERT |
| 5R01 CA077683-08 | FELIX, CAROLYN A | CHILDREN'S HOSPITAL OF PHILADELPHIA | ANTINEOPLASTIC v LEUKEMOGENIC EPIPODOPHYLLOTOXIN EFFECTS | FU, YALI |
| 5R37 CA044848-21 | FENICAL, WILLIAM H | UNIVERSITY OF CALIFORNIA SAN DIEGO | Antitumor-Antibiotics from Marine Microorganisms | FU, YALI |
| 5R01 CA109254-03 | FERNANDES, DANIEL J | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Drug-Induced Destabilization of Bcl-2 mRNA | ARYA, SURESH |
| 1R43 CA117291-01A2 | FEWELL, JASON G. | EXPRESSION GENETICS, INC. | Novel Combination Treatments For Brain Tumors | FU, YALI |
| 1R21 CA122298-01A1 | FISHEL, MELISSA L | INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS | Chemosensitization of Pancreatic Tumors via Inhibition of a DNA BER Enzyme, Ape1 | ARYA, SURESH |
| 5R01 CA098712-05 | FISHER, PAUL B | COLUMBIA UNIVERSITY HEALTH SCIENCES | Novel Approaches for Pancreatic Cancer Therapy | FORRY-SCHAUDIES, SUZANNE |
| 1R43 CA130381-01 | FONG, PETER MARC | CARIGENT THERAPEUTICS | Long Circulating Targeted Nanoparticles for non-Hodgkin's Lymphoma Treatment | FU, YALI |
| 1R43 CA130388-01 | FRACZKIEWICZ, ROBERT | SIMULATIONS PLUS, INC. | Novel In Silico Models for ADMET Using Rapid Estimates of Quantum Chemical Descri | SONG, MIN-KYUNG |
| 5R21 CA122793-02 | FRANK, DAVID A | DANA-FARBER CANCER INSTITUTE | STAT3 in the Pathogenesis and Treatment of Pancreatic Cancer | ARYA, SURESH |
| 5R01 CA113796-02 | FRANK, MARKUS H. | CHILDREN'S HOSPITAL BOSTON | ABCB5 P-Glycoprotein in Cancer Multidrug Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA090410-05 | FRIEDMAN, SIMON H | UNIVERSITY OF MISSOURI KANSAS CITY | Synthetic and Analytical Methods Targeting Telomerase | LEES, ROBERT |
| 5U01 CA060548-15 | FUCHS, PHILIP L | PURDUE UNIVERSITY WEST LAFAYETTE | Synthesis & Mechanism of Cephalostatin Anticancer Drugs | LEES, ROBERT |
| 5R01 CA072937-07 | GALLO, JAMES M. | TEMPLE UNIVERSITY | Interactions Between Cytotoxic and Antiangiogenic Drugs | SONG, MIN-KYUNG |
| 5R01 CA125153-02 | GANGJEE, ALEEM | DUQUESNE UNIVERSITY | Alpha Folate Receptor Mediated GARFTase Inhibitors as Selective Antitumor Agents | LEES, ROBERT |
| 5R01 CA114021-02 | GANGJEE, ALEEM | DUQUESNE UNIVERSITY | Antitumor Antimitotics That Reverse Tumor Resistance | LEES, ROBERT |
| 5R01 CA098850-05 | GANGJEE, ALEEM | DUQUESNE UNIVERSITY | Novel Single, Dual and Multitargeted Inhibitors of RTKs | FU, YALI |
| 1R01 CA122994-01A1 | GAO, JINMING | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | Micellar Nanotherapeutics for Targeted Lung Cancer Therapy | FU, YALI |
| 5R01 CA119131-02 | GATES, KENT S | UNIVERSITY OF MISSOURI-COLUMBIA | Chemical and Biological Mechanisms of Leinamycin | LEES, ROBERT |
| 5R01 CA083925-07 | GATES, KENT S | UNIVERSITY OF MISSOURI-COLUMBIA | DNA Alkylation by Leinamycin | LEES, ROBERT |
| 5R01 CA109312-03 | GERA, JOSEPH F | SEPULVEDA RESEARCH CORPORATION | Mechanisms of AKT-dependent sensitivity to rapamycin | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA086357-08 | GERSON, STANTON L | CASE WESTERN RESERVE UNIVERSITY | Modulating Base Excision Repair in Tumor Drug Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5P01 CA072765-10 | GEWIRTZ, ALAN M | UNIVERSITY OF PENNSYLVANIA | Examing Oligonucleotide Effects on Gene Expression | ARYA, SURESH |
| 5R21 CA116584-02 | GHANDEHARI, HAMID | UNIVERSITY OF MARYLAND BALTIMORE | Recombinant Polymers for Systemic Cancer Gene Therapy | FU, YALI |
| 5R01 CA107621-03 | GHANDEHARI, HAMID | UNIVERSITY OF MARYLAND BALTIMORE | Engineering Polymers For Gene Therapy of Head Cancer | FU, YALI |
| 5R01 CA100202-05 | GIANNAKAKOU, PARASKEVI | WEILL MEDICAL COLLEGE OF CORNELL UNIV | Antitubulin drugs: Mechanisms of action and resistance | FU, YALI |
| 1R01 CA112483-01A2 | GIBBS, RICHARD A | PURDUE UNIVERSITY WEST LAFAYETTE | Inhibition of Prenylated Protein Processing | LEES, ROBERT |
| 5R01 CA078819-08 | GIBBS, RICHARD A | PURDUE UNIVERSITY WEST LAFAYETTE | Chemical Probes of Protein Prenylation | LEES, ROBERT |
| 5R01 CA113344-03 | GLAZER, PETER M | YALE UNIVERSITY | Cisplatin Damage Response and Cell-to-cell Communication | WOLPERT, MARY K. |
| 5U01 CA102532-03 | GMEINER, WILLIAM H | WAKE FOREST UNIVERSITY HEALTH SCIENCES | DNA-DIRECTED EFFECTS OF FdUMP(N) | LEES, ROBERT |
| 5R01 CA082621-09 | GOLDMAN, I DAVID | YESHIVA UNIVERSITY | Carrier Mediated Antifolate Transport and Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA107311-03 | GOTTESFELD, JOEL M | SCRIPPS RESEARCH INSTITUTE | Polyamide-Chl inhibition of cancer cell proliferation | LEES, ROBERT |
| 1R01 CA124975-01A1 | GOYDOS, JAMES S | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH | Validation of Grm1 as a Therapeutic Target in Melanoma | SONG, MIN-KYUNG |
| 1R13 CA128063-01 | GRAINGER, DAVID W | UNIVERSITY OF UTAH | Conference Support: The 13th International Drug Delivery Symposium | FU, YALI |
| 5R01 CA101840-04 | GRANDIS, JENNIFER R | UNIVERSITY OF PITTSBURGH AT PITTSBURGH | Stat3 as a Therapeutic Target in Head and Neck Cancer | ARYA, SURESH |
| 2R01 CA093738-05A2 | GRANT, STEVEN | VIRGINIA COMMONWEALTH UNIVERSITY | NF-kappaB Inhibitors and Differentiation-Inducers in Leukemia | ARYA, SURESH |
| 5R01 CA063753-13 | GRANT, STEVEN | VIRGINIA COMMONWEALTH UNIVERSITY | Promotion of Nucleoside Analog Induced Apoptosis by HDIs | FORRY-SCHAUDIES, SUZANNE |
| 1R21 CA125327-01 | GRINSTAFF, MARK W | BOSTON UNIVERSITY | Nanoscale Functional Dendrimer-DNA Assemblies | FU, YALI |
| 1R01 CA124756-01 | GROMEIER, MATTHIAS | DUKE UNIVERSITY | Targeting Translation Control in Malignant Glioma | ARYA, SURESH |
| 5R01 CA114001-03 | GUNTHER, EDWARD J | PENNSYLVANIA STATE UNIV HERSHEY MED CTR | Preclinical Modeling of Latent Breast Cancer in Mice | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA109582-03 | GUPTA, KALPNA | UNIVERSITY OF MINNESOTA TWIN CITIES | Opioid and Breast Cancer Growth and Metastasis | FORRY-SCHAUDIES, SUZANNE |
| 7R01 CA101988-04 | GUSTAFSON, DANIEL L | COLORADO STATE UNIVERSITY-FORT COLLINS | Dual Compartmental Targeting of Cancer | SONG, MIN-KYUNG |
| 5R01 CA101988-03 | GUSTAFSON, DANIEL L | UNIVERSITY OF COLORADO DENVER/HSC AURORA | Dual Compartmental Targeting of Cancer | SONG, MIN-KYUNG |
| 5R01 CA109181-04 | HALDAR, SUBRATA | CASE WESTERN RESERVE UNIVERSITY | Molecular Targeting of Bcl-xL Pathway in Cancer | ARYA, SURESH |
| 5R01 CA089362-06 | HAMMERLING, ULRICH G | SLOAN-KETTERING INSTITUTE FOR CANCER RES | NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM | LEES, ROBERT |
| 5R01 CA057530-16 | HANIGAN, MARIE H | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR | Significance of GGT Expression in Tumors | WOLPERT, MARY K. |
| 5P01 CA097132-05 | HANNUN, YUSUF AWNI | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Sphingolipids in Cancer Therapy and Angiogenesis | ARYA, SURESH |
| 5R44 CA096409-03 | HANSEN, BRIAN N | AEROPHASE, INC. | Aerosol Therapy for Lung Cancer | FU, YALI |
| 5R01 CA100560-03 | HAUGEN, BRYAN R | UNIVERSITY OF COLORADO DENVER/HSC AURORA | Thiazolidinediones as Thyroid Cancer Therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA097342-05 | HAWTHORNE, M FREDERICK | UNIVERSITY OF MISSOURI-COLUMBIA | Liposome Delivery of Boron for BNCT | FU, YALI |
| 1R01 CA122065-01A1 | HAZLEHURST, LORI A | H. LEE MOFFITT CANCER CTR & RES INST | Role of Bim in mediating CAM-DR in hematopoietic tumors | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA116566-01A2 | HECHT, SIDNEY M | UNIVERSITY OF VIRGINIA CHARLOTTESVILLE | Inhibitors of p90Rsk | LEES, ROBERT |
| 5R01 CA077359-10 | HECHT, SIDNEY MICHAEL | UNIVERSITY OF VIRGINIA CHARLOTTESVILLE | Elaboration of Modified Proteins Using Misacylated tRNAs | FU, YALI |
| 5R01 CA077284-09 | HECHT, SIDNEY MICHAEL | UNIVERSITY OF VIRGINIA CHARLOTTESVILLE | Synthesis of Bleomycin Group Antibiotics and Analogues | LEES, ROBERT |
| 1R01 CA128803-01 | HEMANN, MICHAEL T | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Identifying determinants of chemotherapeutic response in vivo | ARYA, SURESH |
| 3R01 CA098459-03S2 | HEMENWAY, CHARLES S | TULANE UNIVERSITY OF LOUISIANA | Targeted therapy for 11q23 acute leukemias. | ARYA, SURESH |
| 1R01 CA120439-01A2 | HERGENROTHER, PAUL J | UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN | Small Molecule Activators of Procaspases as Anti-Cancer Agents | LEES, ROBERT |
| 1R43 CA128270-01A1 | HERWEIJER, HANS | MIRUS BIO CORPORATION | Targeting of siRNAs, genes and drugs to cancer cells | FU, YALI |
| 5R01 CA122608-02 | HIGGINS, JONATHAN M | BRIGHAM AND WOMEN'S HOSPITAL | Development of a haspin kinase assay for high throughput drug screening | SONG, MIN-KYUNG |
| 5R01CA105305-04 | HIMES, RICHARD H | UNIVERSITY OF KANSAS LAWRENCE | A Yeast Model for Determining Tubulin-drug Interactions | FU, YALI |
| 5R01CA112570-04 | HO, SHUK-MEI | UNIVERSITY OF CINCINNATI | Progesterone-mediated protection against ovarian cancer | ARYA, SURESH |
| 1R01CA124898-01A1 | HORWITZ, SUSAN B | YESHIVA UNIVERSITY | H/D Exchange Coupled to MS to Study Drug-Induced Change in Microtuble Structure | FU, YALI |
| 5R01CA105039-04 | HOSTETLER, KARL Y | VETERANS MEDICAL RESEARCH FDN/SAN DIEGO | Nucleoside Phosphonate Analogs and HPV Positive Cancers | FORRY-SCHAUDIES, SUZANNE |
| 2R01CA087952-06A1 | HOUGHTON, JANET A | CLEVELAND CLINIC LERNER COL/MED-CWRU | TRAIL Therapy for Rhabdomyosacrcoma | ARYA, SURESH |
| 7R01CA032613-25 | HOUGHTON, JANET A | CLEVELAND CLINIC LERNER COL/MED-CWRU | SELECTIVE THERAPY FOR COLON CARCINOMA | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA077776-09 | HOUGHTON, PETER J | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | Rapamycin-induced Selective Apoptosis in Malignant Cells | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA095298-06 | HOWELL, STEPHEN B | UNIVERSITY OF CALIFORNIA SAN DIEGO | Cisplatin resistance mediated by cooper export pathways | WOLPERT, MARY K. |
| 5R01CA113859-02 | HU, MICKEY C-T | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | The Role of Regulation of FOXO3a in Tumor Suppression | ARYA, SURESH |
| 1R01CA124974-01 | HUANG, JING | UNIVERSITY OF CALIFORNIA LOS ANGELES | Exploiting TOR Signaling for Cancer Drug Discovery | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA085563-06 | HUANG, PENG | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Superoxide, ROS, and novel targets for cancer therapy | FORRY-SCHAUDIES, SUZANNE |
| 1R21CA132684-01A2 | HUANG, XI | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | Role of Estrogen and Iron in Breast Cancer | WOLPERT, MARY K. |
| 1R01CA116402-01A1 | HUNTER, TONY | SALK INSTITUTE FOR BIOLOGICAL STUDIES | Checkpoint Kinase Chk1 in Cancer Biology and Therapy | ARYA, SURESH |
| 1R43CA130193-01A1 | HUTCHINSON, CHARLES R | CENTROSE, LLC | cardiac neoglycosides as cancer drugs | LEES, ROBERT |
| 5R01CA104574-04 | ILIOPOULOS, OTHON | MASSACHUSETTS GENERAL HOSPITAL | Molecular targets of hypoxia in signaling cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA109256-04 | IONOV, YURIJ | ROSWELL PARK CANCER INSTITUTE CORP | Using NMD to identify Mutated genes in colon cancer | ARYA, SURESH |
| 1R13CA128082-01 | IRELAND, CHRIS M. | UNIVERSITY OF UTAH | US-Japan Seminar - Frontiers in Marine Natural Products Research | FU, YALI |
| 5U19CA067786-13 | IRELAND, CHRIS M. | UNIVERSITY OF UTAH | ANTICANCER AGENTS FROM UNIQUE NATURAL PRODUCTS SOURCES | FU, YALI |
| 5R01CA036622-25 | IRELAND, CHRIS M. | UNIVERSITY OF UTAH | Antineoplastic Agents from Marine Organisms | FU, YALI |
| 1R01CA127378-01A1 | ISHOV, ALEXANDER M | UNIVERSITY OF FLORIDA | Function of Daxx in mitosis that determines paclitaxel sensitivity in breast canc | SONG, MIN-KYUNG |
| 5U19CA113341-03 | JAFFEE, ELIZABETH M | JOHNS HOPKINS UNIVERSITY | Combinational Immunotherapies to Amplify Vaccine Induce* | WOLPERT, MARY K. |
| 7R01CA081057-09 | JAISWAL, ANIL KUMAR | UNIVERSITY OF MARYLAND BALTIMORE | Mechanisms of Bioreductive Drugs Activation | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA081057-08 | JAISWAL, ANIL KUMAR | BAYLOR COLLEGE OF MEDICINE | Mechanisms of Bioreductive Drugs Activation | FORRY-SCHAUDIES, SUZANNE |
| 1R43CA130402-01A1 | JANSEN, BURKHARD | NOVELIX PHARMACEUTICALS, INC. | Directed Synergy: A New Strategy to Combine Targeted Therapeutics | FU, YALI |
| 1R15CA108864-01A2 | JASTI, BHASKARA RAO | UNIVERSITY OF THE PACIFIC-STOCKTON | Amphiphilic Micellar Carriers with Integrin Binding Motives for Targeted Delivery | FU, YALI |
| 5R01CA116642-03 | JAY, DANIEL G. | TUFTS UNIVERSITY BOSTON | INHIBITING SURFACE HSP90 TO LIMIT METASTASIS | FORRY-SCHAUDIES, SUZANNE |
| 1R01CA116322-01A2 | JI, LIN X | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Tumor and PTK-Targeted Therapy by FUS1 and PTK inhibitor | SONG, MIN-KYUNG |
| 1R01CA109208-01A2 | JIN, ZHENDONG | UNIVERSITY OF IOWA | Total Synthesis of Anticancer Agents Superstolides A & B | LEES, ROBERT |
| 5R01CA057291-15 | JORDAN, MARY A | UNIVERSITY OF CALIFORNIA SANTA BARBARA | Mechanisms of Action of Anti-Mitotic Drugs | FU, YALI |
| 5R01CA095317-03 | JOSHI, HARISH C | EMORY UNIVERSITY | Novel anti-melanoma agents and their mechanism of action | FU, YALI |
| 5R01CA040081-19 | JOULLIE, MADELEINE M | UNIVERSITY OF PENNSYLVANIA | Didemnins and Ustiloxins as Probes of Cell Proliferation | LEES, ROBERT |
| 1R01CA115674-01A1 | JOVE, RICHARD | CITY OF HOPE/BECKMAN RESEARCH INSTITUTE | Inhibitors in Src Signaling for Antitumor Therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA116591-02 | KABANOV, ALEXANDER V | UNIVERSITY OF NEBRASKA MEDICAL CENTER | Polymer Based Gene Delivery | FU, YALI |
| 2R01CA089225-05 | KABANOV, ALEXANDER V | UNIVERSITY OF NEBRASKA MEDICAL CENTER | Interactions of Pluronic block copolymers in drug resistant cancer | FU, YALI |
| 5R01CA100451-05 | KANDEL, JESSICA J | COLUMBIA UNIVERSITY HEALTH SCIENCES | Acquired Resistance to VEGF blockade in Wilms tumor | FORRY-SCHAUDIES, SUZANNE |
| 1R43CA121482-01A1 | KARPEISKY, ALEXANDER | MBC RESEARCH, INC. | Novel bisphosphonates for prostate cancer therapy | LEES, ROBERT |
| 5R01CA085972-07 | KAUFMANN, SCOTT H | MAYO CLINIC COLL OF MEDICINE, ROCHESTER | Preclinical Evaluation of Bcr/Abl-Directed Tyrphostins | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA069008-13 | KAUFMANN, SCOTT H | MAYO CLINIC COLL OF MEDICINE, ROCHESTER | Role of Proteases in Therapy-Induced Apoptosis | ARYA, SURESH |
| 5R01CA106298-04 | KELLEY, MARK R | INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS | Imbalancing DNA BER to enhance Ovarian Tumor Sensitivity | ARYA, SURESH |
| 5R01CA041233-22 | KERBEL, ROBERT S | SUNNYBROOK & WOMEN'S COLL HLTH SCIS CTR | Exploiting Angiogenesis for Induction of Tumor Dormancy | WOLPERT, MARY K. |
| 2R01CA077248-10A1 | KHOSLA, CHAITAN | STANFORD UNIVERSITY | Bacterial Aromatic Polyketide Synthases | FU, YALI |
| 5R01CA066736-13 | KHOSLA, CHAITAN S | STANFORD UNIVERSITY | Engineered Biosynthesis of Novel Macrolactone Polyketide | FU, YALI |
| 5R01CA107070-04 | KIM, SUNG WAN | UNIVERSITY OF UTAH | RGD-Polymer Targeting Plasmid to Angiogenic Endothelium | FU, YALI |
| 1P01CA125066-01A1 | KINGHORN, A DOUGLAS | OHIO STATE UNIVERSITY | Discovery of Anticancer Agents of Diverse Natural Orgin | FU, YALI |
| 5R01CA069571-12 | KINGSTON, DAVID G | VIRGINIA POLYTECHNIC INST AND ST UNIV | STUDIES OF TUBULIN-INTERACTIVE ANTICANCER DRUGS | FU, YALI |
| 5R44CA109864-03 | KIRKPATRICK, LYNN | PROLX PHARMACEUTICALS CORPORATION | PI-3 kinase inhibitor PX-866 as anticancer therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA022215-30 | KISHI, YOSHITO | HARVARD UNIVERSITY | Synthesis of Antitumor Natural Products | LEES, ROBERT |
| 1R01CA124634-01A1 | KISSELEV, ALEXEI F | DARTMOUTH COLLEGE | Different active sites of the proteasome as drug targets in cancer | ARYA, SURESH |
| 1R21CA124811-01A1 | KLINGE, CAROLYN M. | UNIVERSITY OF LOUISVILLE | Regulation of miRNA expression in breast cancer cells | SONG, MIN-KYUNG |
| 5R01CA089325-06 | KMIEC, ERIC B | UNIVERSITY OF DELAWARE | Regulation of Targeted Gene Correction | ARYA, SURESH |
| 5R01CA120792-02 | KOIDE, KAZUNORI | UNIVERSITY OF PITTSBURGH AT PITTSBURGH | Chemical Approaches for the Discovery of New Cancer Therapeutic Targets | LEES, ROBERT |
| 5R01CA042385-22 | KOLESNICK, RICHARD N | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Targeting KSR to Treat Pancreatic Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA095701-05 | KORN, WOLFGANG MICHAEL | UNIVERSITY OF CALIFORNIA SAN FRANCISCO | The Adenovirus Receptor CAR in Epithelial Malignancies | ARYA, SURESH |
| 5R01CA098505-03 | KOUTCHER, JASON | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Cytocidal Therapy In Vivo for Drug-Resistant Tumors | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA109164-04 | KOZLOWSKI, MARISA C | UNIVERSITY OF PENNSYLVANIA | Synthesis of Novel Anticancer Agents | LEES, ROBERT |
| 1U01CA120475-01A1 | KOZMA, SARA C | UNIVERSITY OF CINCINNATI | The Role of mTOR Signaling in Hepatocellular Carcinogenesis | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA104710-05 | KRAFT, ANDREW S | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Mechanisms by which Proteasome Enhance Apoptosis | ARYA, SURESH |
| 5R01CA112091-03 | KRAG, DAVID N | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE | Targeted Enzymes for Prodrug Therapy | SONG, MIN-KYUNG |
| 5R01CA114104-02 | KRIDEL, STEVEN J | WAKE FOREST UNIVERSITY HEALTH SCIENCES | Fatty acid synthase inhibitors and prostate cancer | FORRY-SCHAUDIES, SUZANNE |
| 1P01CA129243-01 | KRIS, MARK G | SLOAN-KETTERING INSTITUTE FOR CANCER RES | New Targets for Therapy for Adenocarcinoma of the Lung | ARYA, SURESH |
| 5R01CA106655-03 | KRISE, JEFFREY P | UNIVERSITY OF KANSAS LAWRENCE | Analysis of Intracellular Drug Sequestration | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA104286-04 | KROLL, DAVID J | RESEARCH TRIANGLE INSTITUTE | Pure Flavonolignans from S. marianum in Prostate Cancer | FU, YALI |
| 5R01CA114574-02 | KRUH, GARY D | FOX CHASE CANCER CENTER | Functions of MRP2 and MRP3 in Drug Disposition | SONG, MIN-KYUNG |
| 5R01CA095030-03 | KRUPENKO, SERGEY A | MEDICAL UNIVERSITY OF SOUTH CAROLINA | FDH: A Novel Determinant of Tumor Suppression | ARYA, SURESH |
| 5R01CA104729-05 | KRYNETSKIY, EVGENY | TEMPLE UNIVERSITY | HMGB1/2 and Cellular Response to Fraudulent Nucleosides | ARYA, SURESH |
| 1R43CA130224-01 | KUMAR, NALIN | UHV TECHNOLOGIES, INC. | A Two Hybrid System Based Yeasy Screen for Agents that Affect DNA Damage Checkpoi | SONG, MIN-KYUNG |
| 1R03CA129786-01 | KUMARESAN, PAPPANAICKEN | UNIVERSITY OF CALIFORNIA DAVIS | Identification of pancreatic cancer specific high affinity targeting ligands | LEES, ROBERT |
| 5R01CA089541-04 | KUO, MACUS T | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Genomic Instability and Evolution of Drug Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA079085-05 | KUO, MACUS T | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Redox Regulation of Multidrug Resistance Gene Expression | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA102264-04 | KUPPUSAMY, PERIANNAN | OHIO STATE UNIVERSITY | In Vivo EPR Imaging of Redox Status and Thiols in Tumor | LEES, ROBERT |
| 5R01CA107575-04 | KYPRIANOU, NATASHA | UNIVERSITY OF KENTUCKY | Anoikis Effect by Quinazolines on Prostate Growth | ARYA, SURESH |
| 7R21CA121751-02 | LABHASETWAR, VINOD D | CLEVELAND CLINIC LERNER COL/MED-CWRU | Drug Resistance in Cancer Therapy | FU, YALI |
| 1R21CA128501-01 | LAM, KIT S | UNIVERSITY OF CALIFORNIA DAVIS | High affinity ligand to deliver nanoparticle drugs to lymphoid cancers | FU, YALI |
| 5R01CA115483-03 | LAM, KIT S | UNIVERSITY OF CALIFORNIA DAVIS | Therapeutic Targeting Agents for Ovarian Cancer | FU, YALI |
| 5U19CA113298-03 | LAM, KIT S | UNIVERSITY OF CALIFORNIA DAVIS | Targeting Agents for Human and Canine Lymphoma | SONG, MIN-KYUNG |
| 5R01CA098116-05 | LAM, KIT S | UNIVERSITY OF CALIFORNIA DAVIS | c-src inhibitors from novel encoded chemical libraries | FU, YALI |
| 1R01CA120847-01A1 | LAMBERT, PAUL F | UNIVERSITY OF WISCONSIN MADISON | Role of Estrogen in Cervical Cancer | FORRY-SCHAUDIES, SUZANNE |
| 2R01CA037109-18A2 | LAMPIDIS, THEODORE J | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | Anti-tumor Activity of Sugar Analogs via Blocking Glycolysis vs Glycosylation | FORRY-SCHAUDIES, SUZANNE |
| 1R41CA126155-01A1 | LANDRY, CHRISTOPHER | APOLLO SRI, LLC | Improving the Transfer of ERK siRNA Constructs Using Nanoporous Silica | FU, YALI |
| 5R01CA113843-03 | LAVIE, ARNON | UNIVERSITY OF ILLINOIS AT CHICAGO | Enhancing the efficacy of nucleoside analogs | FU, YALI |
| 5P01CA078039-08 | LAZO, JOHN S | UNIVERSITY OF PITTSBURGH AT PITTSBURGH | Combinatorial Approaches for Novel Anticancer Agents | LEES, ROBERT |
| 5R01CA076560-06 | LEBIODA, LUKASZ | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA | Thymidylate Synthases: Modes of Catalysis and Inhibition | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA100816-04 | LEE, HO-YOUNG | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Novel Strategy for Lung Cancer Treatment using IGFBP-3 | ARYA, SURESH |
| 5R01CA017625-30 | LEE, KUO-HSIUNG | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | PLANT ANTITUMOR AGENTS | FU, YALI |
| 5R01CA095673-05 | LEE, ROBERT J. | OHIO STATE UNIVERSITY | Targeted Liposomal Doxorubicin Delivery to Leukemia | FU, YALI |
| 1R01CA129974-01A1 | LETAI, ANTHONY G | DANA-FARBER CANCER INSTITUTE | A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC | ARYA, SURESH |
| 5R01CA109481-04 | LI, FENGZHI | ROSWELL PARK CANCER INSTITUTE CORP | Survivin expression and cancer cell drug resistance | FU, YALI |
| 5R01CA109574-03 | LI, KAIYI | BAYLOR COLLEGE OF MEDICINE | RNAi-Based Therapy of Hepatocellular Carcinoma | ARYA, SURESH |
| 1R21CA128415-01 | LI, SONG | |||